Daniel B. Soland - Jun 22, 2021 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Director
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Stock symbol
ACAD
Transactions as of
Jun 22, 2021
Transactions value $
$0
Form type
4
Date filed
6/5/2023, 09:46 PM
Previous filing
Jun 21, 2021
Next filing
Jul 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +3.06K +30.59% 13.1K Jun 22, 2021 Direct F1
transaction ACAD Common Stock Options Exercise +6.39K +48.94% 19.5K Jun 7, 2022 Direct F1
transaction ACAD Common Stock Options Exercise +8.55K +43.97% 28K Jun 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -3.06K -100% $0.00* 0 Jun 22, 2021 Common Stock 3.06K Direct F1, F2
transaction ACAD Restricted Stock Units Options Exercise $0 -6.39K -100% $0.00* 0 Jun 7, 2022 Common Stock 6.39K Direct F1, F2
transaction ACAD Restricted Stock Units Options Exercise $0 -8.55K -100% $0.00* 0 Jun 1, 2023 Common Stock 8.55K Direct F1, F2
transaction ACAD Director Stock Options (Right to Buy) Award $0 +11K $0.00 11K Jun 1, 2023 Common Stock 11K $23.90 Direct F3
transaction ACAD Restricted Stock Units Award $0 +6.65K $0.00 6.65K Jun 1, 2023 Common Stock 6.65K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
F2 The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date.
F3 The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date.